Literature DB >> 35760872

Brown adipose tissue-derived MaR2 contributes to cold-induced resolution of inflammation.

Satoru Sugimoto1, Hebe Agustina Mena2, Brian E Sansbury2, Shio Kobayashi3, Tadataka Tsuji1, Chih-Hao Wang1, Xuanzhi Yin2, Tian Lian Huang1, Joji Kusuyama1, Sean D Kodani1, Justin Darcy1, Gerson Profeta1, Nayara Pereira4, Rudolph E Tanzi5, Can Zhang5, Thomas Serwold3, Efi Kokkotou6, Laurie J Goodyear1, Aaron M Cypess7, Luiz Osório Leiria1,4, Matthew Spite8, Yu-Hua Tseng9,10.   

Abstract

Obesity induces chronic inflammation resulting in insulin resistance and metabolic disorders. Cold exposure can improve insulin sensitivity in humans and rodents, but the mechanisms have not been fully elucidated. Here, we find that cold resolves obesity-induced inflammation and insulin resistance and improves glucose tolerance in diet-induced obese mice. The beneficial effects of cold exposure on improving obesity-induced inflammation and insulin resistance depend on brown adipose tissue (BAT) and liver. Using targeted liquid chromatography with tandem mass spectrometry, we discovered that cold and β3-adrenergic stimulation promote BAT to produce maresin 2 (MaR2), a member of the specialized pro-resolving mediators of bioactive lipids that play a role in the resolution of inflammation. Notably, MaR2 reduces inflammation in obesity in part by targeting macrophages in the liver. Thus, BAT-derived MaR2 could contribute to the beneficial effects of BAT activation in resolving obesity-induced inflammation and may inform therapeutic approaches to combat obesity and its complications.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35760872     DOI: 10.1038/s42255-022-00590-0

Source DB:  PubMed          Journal:  Nat Metab        ISSN: 2522-5812


  76 in total

Review 1.  Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators.

Authors:  Charles N Serhan; Bruce D Levy
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

Review 2.  Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.

Authors:  Nathalie Esser; Sylvie Legrand-Poels; Jacques Piette; André J Scheen; Nicolas Paquot
Journal:  Diabetes Res Clin Pract       Date:  2014-04-13       Impact factor: 5.602

3.  Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain.

Authors:  Charles N Serhan; Jesmond Dalli; Sergey Karamnov; Alexander Choi; Chul-Kyu Park; Zhen-Zhong Xu; Ru-Rong Ji; Min Zhu; Nicos A Petasis
Journal:  FASEB J       Date:  2012-01-17       Impact factor: 5.191

4.  Biosynthesis of D-Series Resolvins in Skin Provides Insights into their Role in Tissue Repair.

Authors:  Jason Hellmann; Brian E Sansbury; Blenda Wong; Xiaofeng Li; Mansher Singh; Kristo Nuutila; Nan Chiang; Elof Eriksson; Charles N Serhan; Matthew Spite
Journal:  J Invest Dermatol       Date:  2018-03-17       Impact factor: 8.551

Review 5.  Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases.

Authors:  Matthew Spite; Joan Clària; Charles N Serhan
Journal:  Cell Metab       Date:  2013-11-14       Impact factor: 27.287

6.  Obesity is associated with macrophage accumulation in adipose tissue.

Authors:  Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 7.  Pro-resolving lipid mediators are leads for resolution physiology.

Authors:  Charles N Serhan
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

8.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.

Authors:  G S Hotamisligil; P Arner; J F Caro; R L Atkinson; B M Spiegelman
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

Review 9.  Obesity: global epidemiology and pathogenesis.

Authors:  Matthias Blüher
Journal:  Nat Rev Endocrinol       Date:  2019-05       Impact factor: 43.330

Review 10.  Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection.

Authors:  Anandita Pal; Kymberly M Gowdy; Kenneth J Oestreich; Melinda Beck; Saame Raza Shaikh
Journal:  Front Immunol       Date:  2020-08-11       Impact factor: 7.561

View more
  1 in total

1.  Drug-Initiated Activity Metabolomics Identifies Myristoylglycine as a Potent Endogenous Metabolite for Human Brown Fat Differentiation.

Authors:  Carlos Guijas; Andrew To; J Rafael Montenegro-Burke; Xavier Domingo-Almenara; Zaida Alipio-Gloria; Bernard P Kok; Enrique Saez; Nicole H Alvarez; Kristen A Johnson; Gary Siuzdak
Journal:  Metabolites       Date:  2022-08-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.